CompletedPHASE1, PHASE2NCT01120964
Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol
Studying Atrioventricular septal defect
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Asklepion Pharmaceuticals, LLC
- Principal Investigator
- Frederick E Barr, MDBatson Children's Hospital, University of Mississippi Medical Center
- Intervention
- Intravenous L-Citrulline(drug)
- Enrollment
- 22 enrolled
- Eligibility
- 6 years · All sexes
- Timeline
- 2010 – 2012
Study locations (2)
- Washington University Children's Hospital, St Louis, Missouri, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01120964 on ClinicalTrials.govOther trials for Atrioventricular septal defect
Additional recruiting or active studies for the same condition.